waldenstrom's macroglobulinemia refractory
Showing 1 - 4 of 4
Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory Trial
Not yet recruiting
- Waldenstrom Macroglobulinemia
- +2 more
- (no location specified)
Jul 18, 2023
Patients Previously Treated WithMustang Bio CAR-T Cell
Enrolling by invitation
- Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- +10 more
- Prior MB-102 CAR-T cell investigational product.
- Prior MB-106 CAR-T cell investigational product.
-
Duarte, California
- +4 more
Dec 8, 2022
Follicular B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Recurrent, Mantle Cell Lymphoma Refractory Trial in Orange,
Recruiting
- Follicular B-cell Non-Hodgkin's Lymphoma
- +7 more
- MB-106
-
Orange, California
- +3 more
Nov 1, 2022
Waldenstrom Macroglobulinemia, Waldenstrom's Disease, Waldenström; Hypergammaglobulinemia Trial in New York (Ibrutinib,
Recruiting
- Waldenstrom Macroglobulinemia
- +6 more
-
New York, New YorkWeill Cornell Medicine
Dec 21, 2021